Chemical Compound
[1,1'-Biphenyl]-4-pentanoic acid, ?-[(3-carboxy-1-oxopropyl)amino]-a-methyl-, a-ethyl ester, (aR,?S)-; [1,1'-Biphenyl]-4-pentanoic acid, ?-[(3-carboxy-1-oxopropyl)amino]-a-methyl-, ethyl ester, [S-(R*,S*)]-; (2R,4S)-4-[(3-Carboxy-1-oxopropyl)amino]-4-[(p-phenylphenyl)methyl]-2-methylbutanoic acid ethyl ester; (2R,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester; AHU 377; Sacubitril; Sucabitril
CAS Registry Number
149709-62-6
Primary record
[1,1'-Biphenyl]-4-pentanoic acid, ?-[(3-carboxy-1-oxopropyl)amino]-a-methyl-, a-ethyl ester, (aR,?S)-; [1,1'-Biphenyl]-4-pentanoic acid, ?-[(3-carboxy-1-oxopropyl)amino]-a-methyl-, ethyl ester, [S-(R*,S*)]-; (2R,4S)-4-[(3-Carboxy-1-oxopropyl)amino]-4-[(p-phenylphenyl)methyl]-2-methylbutanoic acid ethyl ester; (2R,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester; AHU 377; Sacubitril; Sucabitril
- 库存
- 9,301 克
- 纯度
- 98.4 %
- CAS
- 149709-62-6
化合物标识与属性
- CAS
- 149709-62-6
- PubChem CID
- 9811834
- SMILES
- CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O
- Canonical SMILES
- CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)CCC(=O)O
名称与同义词
- Sacubitril
- 149709-62-6
- sucabitril
- AHU-377
- Sacubitrilo
- sacubitrilum
- AHU377
- Entresto
- Neparvis
- 17ERJ0MKGI
- AHU 377
- AHU-377(Sacubitril)
- Sacubitril [USAN:INN]
- UNII-17ERJ0MKGI
- MFCD00920862
- SACUBITRIL [MI]
- SACUBITRIL [INN]
- SACUBITRIL [JAN]
- RefChem:884341
- SACUBITRIL [USAN]
- LCZ-696 Impurity 3
- C24H29NO5
- SACUBITRIL [WHO-DD]
- Sacubitril (JAN/USAN/INN)
- DTXSID20164370
- AMBZ0404
- GTPL7857
- orb1302745
- Sacubitril - Bio-X trade mark
- SCHEMBL2707112
- CHEMBL3137301
- DTXCID3086861
- ENTRESTO COMPONENT SACUBITRIL
- SACUBITRIL [ORANGE BOOK]
- AOB2046
- 4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid
- CHEBI:134714
- PYNXFZCZUAOOQC-UTKZUKDTSA-N
- GLXC-04735
- CS-AV-00004
- ZINC3792417
- EBC-26994
- MSK160284
- AKOS027321509
- ACN-036256
- AM85599
- CID9811834
- CM14438
- CS-2119
- DB09292
- FB71505
- CID:9811834
- NCGC00387800-02
- AC-28899
- AS-16703
- BC600297
- FS183789
- HY-15407
- SC-97604
- SY116093
- SID:463798070
- NS00069205
- J3.050.252C
- A13682
- D10225
- EN300-303419
- ENTRESTO (Trade name, with Valsartan Sodium)
- (2R,4S)-5-(biphenyl-4-yl)-4-((3-carboxypropionyl)amino)-2-methylpentanoic acid ethyl ester
- 4-[[(2S,4R)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoic acid
- A854858
- F869342
- BRD-K91456750-001-01-9
- BRD-K91456750-238-01-7
- Q17811448
- C000717211
- 3-{[(2S,4R)-5-Ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]carbamoyl}propanoic acid
- B0084-458470
- [1,1'-Biphenyl]-4-pentanoic acid, gamma-[(3-carboxy-1-oxopropyl)amino]-alpha-methyl-, alpha-ethyl ester, (alphaR,gammaS)-
- 3-{[(2S,4R)-1-{[1,1'-biphenyl]-4-yl}-5-ethoxy-4-methyl-5-oxopentan-2-yl]carbamoyl}propanoic acid
- 4-(((2S,4R)-1-([1,1-biphenyl]-4-yl)-5-ethoxy-4-Methyl-5-oxopentan-2-yl)aMino)-4-oxobutanoic acid
- alpha-ethyl (alphaR,gammaS)-gamma-<(3-carboxy-1-oxopropyl)amino>-alpha-methyl<1,1'-biphenyl>-4-pentanoate
- (2R, 4S)-5-biphenyl-4-yl-5-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester
- (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester
- (2R,4S)-5-Biphenyl-4-yl-4-(3-carboxypropionylamino)-2-methylpentanoic acid ethyl ester
- 3-[[(2R,4S)-4-ethoxycarbonyl-1-(4-phenylphenyl)pentan-2-yl]carbamoyl]propanoic Acid
- 4-[[(2S,4R)-1-(4-Biphenylyl)-5-ethoxy-4-methyl-5-oxo-2-pentyl]amino]-4-oxobutanoic Acid
- (2R,4S)-4-[(3-Carboxy-1-oxopropyl)amino]-4-[(p-phenylphenyl)methyl]-2-methylbutanoic acid ethyl ester
- (2R,4S)-5-(4-Biphenylyl)-4-[(3-carboxypropanoyl)amino]-2-methylpentanoic acid 1-ethyl ester
- (2R,4S)-5-(biphenyl-4-yl)-4-((3-carboxypropionyl) amino)-2-methylpentanoic acid ethyl ester
- (alphaR,gammaS)-gamma-[(3-Carboxy-1-oxopropyl)amino]-alpha-methyl-4-biphenylpentanoic acid alpha-ethyl ester
- [1,1'-Biphenyl]-4-pentanoic acid, -[(3-carboxy-1-oxopropyl)amino]-alpha-methyl-, alpha-ethyl ester, (alphaR,S)-
- [1,1'-Biphenyl]-4-pentanoic acid, ?-[(3-carboxy-1-oxopropyl)amino]-a-methyl-, a-ethyl ester, (aR,?S)-; [1,1'-Biphenyl]-4-pentanoic acid, ?-[(3-carboxy-1-oxopropyl)amino]-a-methyl-, ethyl ester, [S-(R*,S*)]-; (2R,4S)-4-[(3-Carboxy-1-oxopropyl)amino]-4-[(p-phenylphenyl)methyl]-2-methylbutanoic acid ethyl ester; (2R,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester; AHU 377; Sacubitril; Sucabitril
- [1,1'-Biphenyl]-4-pentanoic acid, |A-[(3-carboxy-1-oxopropyl)amino]-|A-methyl-, |A-ethyl ester, (|AR,|AS)-
- 1038924-61-6
- 3-(((2S,4R)-1-((1,1'-biphenyl)-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)carbamoyl)propanoic acid
- 4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoicacid
- 4-(((2S,4R)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl)amino)-4-oxobutanoic acid
- 4-[[(1S,3R)-1-(Biphenyl-4-ylmethyl)-4-ethoxy-3-methyl-4-oxobutyl]amino]-4-oxobutanoic acid
- 4-[[(1S,3R)-4-ethoxy-3-methyl-4-oxo-1-[(4-phenylphenyl)methyl]butyl]amino]-4-oxo-butanoic acid
- 4-{[(2S,4R)-1-([1,1'-Biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl]amino}-4-oxobutanoic acid
- 810-278-2